A dual-center study: can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels?
British Journal of Radiology · 2024
DOI: 10.1093/bjr/tqae144 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift British Journal of Radiology, 2024. Verfasst von Lixuan Chen und 9 weiteren Autor:innen. Beteiligte Einrichtung: The Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China. Hauptthemen laut MEDLINE: CA-125 Antigen, Carcinoma, Ovarian Epithelial, Ultrasonography, Ovarian Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wenzhou Science and Technology Foundation.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objective
CA125 is recommended by many countries as the primary screening test for ovarian cancer. But there are patients with ovarian cancer having normal CA125. We hope to identify the types of EOC with normal CA125 levels better by building a refined model based on the ultrasound radiomics, thus providing precise medical treatment for patients.
Methods
We included 58 patients with EOC with normal CA125 from 2 centres, who were confirmed by preoperative ultrasound and pathology. We extracted 1130 radiomics features based on the tumour’s region of interest from the most typical ultrasound image of each patient. We selected radiomics and clinical features by LASSO and logistic regression to construct Rad-score and clinical models, respectively. Receiver operating characteristic curves judged their test efficacy. On the basis of the combined model, we developed a nomogram.
Results
Area under the curves (AUCs) of 0.93 and 0.83 were achieved in both the training and test groups for the combined model. There were similar AUCs between the Rad-score and clinical models of 0.82 and 0.80, respectively. By analysing the calibration curves, it was determined that the nomogram matched actual observations in the training cohort.
Conclusion
Ultrasound radiomics can differentiate type I and type II EOC with normal CA125 levels. Advances in knowledge This study is the first to focus on EOC cases with normal level of CA125. The subset of patients constituting 20% of the disease population may require more refined radiomics models.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Department of Radiology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
- Department of Ultrasound, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, China.
- The Department of Medical Record, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
- Department of Obstetrics and Gynecology Ultrasound, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215000, China.
- The Department of Nuclear, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
- The Department of Ultrasound, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou 325000, China.
ORCID-Profile: Yunjun Yang, Li Lan
Förderung
- Wenzhou Science and Technology Foundation
Zitieren
APA
Chen, L., Jin, C., Chen, B., Debora, A., Su, W., Zhou, Q., Zhou, S., Bian, J., Yang, Y., & Lan, L. (2024). A dual-center study: can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels?. British Journal of Radiology. https://doi.org/10.1093/bjr/tqae144
Vancouver
Chen L, Jin C, Chen B, Debora A, Su W, Zhou Q, et al. A dual-center study: can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels?. British Journal of Radiology. 2024. doi:10.1093/bjr/tqae144
BibTeX
@article{Chen2024,
author = {Chen, Lixuan and Jin, Chenyang and Chen, Bo and Debora, Asta and Su, Weizeng and Zhou, Qingwen and Zhou, Shuai and Bian, Jinyan and Yang, Yunjun and Lan, Li},
title = {A dual-center study: can ultrasound radiomics differentiate type I and type II epithelial ovarian cancer patients with normal CA125 levels?},
journal = {British Journal of Radiology},
year = {2024},
doi = {10.1093/bjr/tqae144}
}
EUVIMED